Aptinyx Stock Price, News & Analysis

APTX OTC

Company Description

Aptinyx (OTC: APTX) is a publicly traded pharmaceutical preparation manufacturing company in the Manufacturing sector.

APTX stock has declined 100.0% over the past year.

This page provides a comprehensive overview of APTX stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart

$—

0.00%

0.00

Last updated:

-100%

Performance 1 year

$0.0

Market Cap

67.7M

Shares outstanding

Aptinyx (APTX) stock. Over the past 12 months, the stock has lost 100.0%.

Latest News

View All

April 23, 2024

0.00%

Tentarix Biotherapeutics Announces the Appointment of Andrew D. Kidd, MD, CFA, as CEO

management

March 30, 2023

-6.52%

Aptinyx Reports on Fourth Quarter and Full Year 2022 Results and Highlights and Review of Strategic Alternatives

earnings

February 27, 2023

-66.78%

Aptinyx Reports Results from Phase 2 Study of NYX-458 in Cognitive Impairment Associated with Parkinson';s Disease and Dementia with Lewy Bodies and Provides Pipeline and Corporate Update

clinical trial

January 31, 2023

+19.02%

Aptinyx to Present at the SVB Securities Global Biopharma Conference

conferences

November 10, 2022

-8.39%

Preclinical Data from Aptinyx’s NMDA Receptor Modulators to be Presented at the 52nd Annual Meeting of the Society for Neuroscience

clinical trial

November 8, 2022

-13.37%

Aptinyx Reports Third Quarter 2022 Financial Results and Recent Highlights

earnings

Aptinyx has 10 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 5 with negative movement. Key topics include management, earnings, clinical trial, conferences. View all APTX news →

SEC Filings

View All

No SEC filings available for APTX.

Financial Highlights

View Full Financials

—

Revenue (TTM)

—

Net Income (TTM)

—

Diluted EPS (TTM)

—

Operating Cash Flow

—

Net Profit Margin

—

Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

APTX Company Profile & Sector Positioning

Aptinyx (APTX) operates in the Pharmaceutical Preparation Manufacturing industry within the broader Manufacturing sector and is listed on the OTC.